Skip to main content

TYVASO is approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

Skip to main content
Hamburger button
Close button

Cost assistance

ASSIST can help you determine if you qualify for United Therapeutics’ patient assistance programs.
Call ASSIST at 1-877-864-8437.

Pay as little as $5 per prescription

With the Co-Pay Assistance Card, eligible patients taking TYVASO who enroll may pay as little as a $5 co-pay per month and may receive up to $8000 in savings per year.*

Enroll today

Learn how to enroll at www.UTcopay.com or call ASSIST at 1-877-864-8437.

Get full Program details and Terms and Conditions.

*Eligibility requirements for this Program are:

  • You must be 18 years or older to use this Program
  • The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication
  • Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
  • Eligible patients must be a resident of the United States or Puerto Rico
  • The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program